The Patent Finder
ME

MedImmune, LLC

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

203 patents currently held

58 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2027. from the record

Of the 58 now held by other companies, 9 name Humabs Biomed S.A. as their current owner, and 49 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
21
Ending by 2030
Jan 2027
Next term end
125
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 16, 2026
    The maintenance fee for Pyrrolobenzodiazepine Conjugates (US 11,649,250) comes due Nov 16, 2026. Unpaid by May 17, 2027, it lapses early.
  • 2 fees due Dec 2 to 6, 2026 · next Dec 2
  • 3 fees due Jan 2 to 16, 2027 · next Jan 2
  • 2 fees due Feb 6 to 28, 2027 · next Feb 6
  • 4 fees due Mar 1 to 26, 2027 · next Mar 1
  • 8 fees due Apr 3 to 29, 2027 · next Apr 3
  • 5 fees due May 3 to 28, 2027 · next May 3
  • 5 fees due Jun 15 to 30, 2027 · next Jun 15
  • 2 fees due Jul 14 to 28, 2027 · next Jul 14
  • 6 fees due Aug 9 to 27, 2027 · next Aug 9
  • 5 fees due Sep 3 to 26, 2027 · next Sep 3
  • 2 fees due Oct 30, 2027

Which patents, and when each one lapses · Pro

Recent changes

What they patent

The 5 largest of its 125 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 7,670,837Non-Tumorigenic MDCK Cell Line for Propagating Viruses
In force
 · High confidence
In forceHigh confidence
US 8,846,032MDCK Cell Lines Supporting Viral Growth to High Titers and Bioreactor Process Using the Same
In force
 · High confidence
In forceHigh confidence
US 9,005,620Compounds
In force
 · Medium confidence
In forceMedium confidence
US 8,008,443Modulation of Antibody Effector Function by Hinge Domain Engineering
In force
 · High confidence
In forceHigh confidence
US 8,666,778Systems and Methods for Processing Requests for Pharmaceuticals That Require Insurer Preapproval
In force
 · Medium confidence
In forceMedium confidence
US 7,790,655Cell Display of Antibody Libraries
In force
 · High confidence
In forceHigh confidence
US 7,790,434Methods and Compositions for Expressing Negative-Sense Viral RNA in Canine Cells
In force
 · High confidence
In forceHigh confidence
US 9,176,129Protein Scaffolds
In force
 · High confidence
In forceHigh confidence
US 8,137,670Method of Identifying Membrane Ige Specific Antibodies and Use Thereof for Targeting Ige Producing Precursor Cells
In force
 · High confidence
In forceHigh confidence
US 9,193,789Anti-Icos Antibodies and Their Use in Treatment of Oncology, Transplantation and Autoimmune Disease
In force
 · Medium confidence
In forceMedium confidence
10 of 203 patents shown.
Pro members see all 203.
Pro members: see all 203 patents
Also on record, not counted in the 203: 58 patents in force now held by others · 217 patents ended · 144 applications pending · 367 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited